PFE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Pfizer Inc's account receivable for the three months ended in Dec. 2013 was $9,357 Mil. Pfizer Inc's revenue for the three months ended in Dec. 2013 was $13,558 Mil. Hence, Pfizer Inc's days sales outstanding for the three months ended in Dec. 2013 was 62.80.
Pfizer Inc's days sales outstanding declined from Dec. 2012 (69.93) to Dec. 2013 (62.80).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Pfizer Inc's Days Sales Outstanding for the fiscal year that ended in Dec. 2013 is calculated as
Pfizer Inc's Days Sales Outstanding for the quarter that ended in Dec. 2013 is calculated as:
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Pfizer Inc Annual Data
Pfizer Inc Quarterly Data